Donald Chancellor E, Kahn Marc J
Section of Hematology and Medical Oncology, Department of Medicine, Tulane University School of Medicine, New Orleans, Louisiana 70112, USA.
Am J Med Sci. 2009 Jan;337(1):65-6. doi: 10.1097/MAJ.0b013e318169569a.
A 63-year-old man with lymphocytic variant hypereosinophilic syndrome (HES) characterized by a T-cell receptor gene rearrangement was treated with cyclosporine with marked improvement in his symptoms and reduction in his total eosinophil count. We present this as the first report to demonstrate cyclosporine as an effective treatment of HES in an adult.
